Financial reports
No filings
Current reports
No filings
Registration and prospectus
Proxies
No filings
Other
No filings
Ownership
SC 13G/A
Aclaris Therapeutics, Inc.
11 Feb 22
4
James B. Tananbaum
3 Nov 21
SC 13G/A
CymaBay Therapeutics, Inc.
16 Feb 21
SC 13G/A
Aclaris Therapeutics, Inc.
11 Feb 21
3
James B. Tananbaum
10 Feb 21
SC 13G
Aclaris Therapeutics, Inc.
27 Oct 20
4
James B. Tananbaum
2 Mar 20
SC 13G/A
CymaBay Therapeutics, Inc.
14 Feb 20
SC 13G/A
Replimune Group, Inc.
14 Feb 20
3/A
James B. Tananbaum
5 Nov 19